How to Manage Controlled Substance Investigational Products in Clinical Trials
How to Manage Controlled Substance Investigational Products in Clinical Trials Best Practices for Managing Controlled Substance Investigational Products in Clinical Trials Managing controlled substances in clinical trials requires an advanced level of oversight, security, and compliance. These substances—often Schedule I-IV drugs—carry a high risk of abuse or diversion and are strictly regulated by national authorities…
Read More “How to Manage Controlled Substance Investigational Products in Clinical Trials” »